ArticleScientific reports2025
Improving lung cancer detection with enhanced convolutional sequential networks.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prediction of chemoresistance in ovarian cancer based on deep learning with pathological images.Functional & integrative genomics · 2026Article
- Clinical validation of lightweight CNN architectures for reliable multi-class classification of lung cancer using histopathological imaging techniques.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Lung cancer is the most common cause of cancer-related deaths worldwide, and early detection is extremely important for improving survival. According to the National Institute of Health Sciences, lung cancer has the highest rate of cancer mortality, according to the National Institute of Health Sciences. Medical professionals are usually based on clinical imaging methods such as MRI, X-ray, biopsy, ultrasound, and CT scans. However, these imaging techniques often face challenges including false positives, false negatives, and sensitivity. Deep learning approaches, particularly folding networks (CNNS), have arisen as they tackle these issues. However, traditional CNN models often suffer from high computing complexity, slow inference times and over adaptation in real-world clinical data. To overcome these limitations, we propose an optimized sequential folding network (SCNN) that maintains a high level of classification accuracy, simultaneously reducing processing time and computing load. The SCNN model consists of three folding layers, three maximum pooling layers, flat layers and dense layers, allowing for efficient and accurate classification. In the histological imaging dataset, three categories of lung cancer models are adenocarcinoma, benign and squamous cell carcinoma. Our SCNN achieves an average accuracy of 95.34%, an accuracy of 95.66%, a recall of 95.33%, and an F1 score of over 60 epochs within 1000 seconds. These results go beyond traditional CNN, R-CNN, and custom inception classifiers, indicating superior speed and robustness in histological image classification. Therefore, SCNN offers a practical and scalable solution to improve lung cancer awareness in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.